Investing.com - Pulse Biosciences reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Pulse Biosciences announced earnings per share of $-0.49 on revenue of $200K. Analysts polled by Investing.com EPS of $-0.44 on revenue of $300K.
Pulse Biosciences 's are down 53.92% and is trading at $2.08 , still down 90.95% from its 52 week high of $22.99 set on Tuesday, November 16, 2021.
Pulse Biosciences follows other major Healthcare sector earnings this month
Pulse Biosciences's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar